Jürgen Ripperger

Dr. Jürgen Ripperger

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2011 in FEBS Letters
Verified
Journal Article
Closed access
JRJürgen Ripperger
Jürgen Ripperger
CJCorinne Jud
Corinne Jud
Urs AlbrechtUrs Albrecht
Urs Albrecht

15 June 2010 in Genes & Development
Verified
Journal Article
Closed access
PDF file
MSMarkus Stratmann
Markus Stratmann
FSFrédéric Stadler
Frédéric Stadler
FTFilippo Tamanini
Filippo Tamanini
GHGijsbertus T. J. Van Der Horst
Gijsbertus T. J. Van Der Horst
JRJürgen Ripperger
Jürgen Ripperger
The albumin D site-binding protein (DBP) governs circadian transcription of a number of hepatic detoxification and metabolic enzymes prior to the activity phase and subsequent food intake of mice. However, the behavior of mice is drastically affected by the photoperiod. Therefore, continuous adjustment of the phase of circadian Dbp expression is required in the liver. Here we describe a direct impact of CRYPTOCHROME1 (CRY1) on the phase of Dbp expression. Dbp and the nuclear receptor Rev-Erbα are circadian target genes of BMAL1 and CLOCK. Surprisingly, dynamic CRY1 binding to the Dbp promoter region delayed BMAL1 and CLOCK-mediated transcription of Dbp compared with Rev-Erbα. Extended presence of CRY1 in the nucleus enabled continuous uncoupling of the phase of Dbp from Rev-Erbα expression upon change from short to longer photoperiods. CRY1 thus maintained the peak of DBP accumulation close to the activity phase. In contrast, Rev-Erbα expression was phase-locked to the circadian oscillator and shaped by accumulation of its own gene product. Our data indicate that fine-tuning of circadian transcription in the liver is even more sophisticated than expected.

6 March 2015 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
SCSara S. Fonseca Costa
Sara S. Fonseca Costa
JRJürgen Ripperger
Jürgen Ripperger
The increase of life expectancy and the decline of biological functions with advancing age are impending obstacles for our society. In general, age-related changes can be separated into two processes. Primary aging is based on programs governing gradual changes which are generally not harmful. On the other hand, secondary aging or senescence is more aleatory in nature and it is at this stage that the progressive impairment of metabolic, physiological and neurological functions increases the risk of death. Exploiting genetic animal models, we obtain more and more information on the underlying regulatory networks. The aim of this review is to identify potential links between the output of the circadian oscillator and secondary aging. The reasons to suspect such links rely on the fact that the mouse models without functional circadian clocks sometimes exhibit reduced life expectancy. This may be due to their inability to properly control and synchronize energy expenditure, affecting for example, the integrity of neurons in the brain. Hence, it is tempting to speculate that re-synchronization of metabolic and physiological functions by the circadian clock may slow down the aging process.

5 November 2019 in eLife
Verified
Journal Article
Open access
ABAndrea Brenna
Andrea Brenna
IOIwona Olejniczak
Iwona Olejniczak
RCRohit Chavan
Rohit Chavan
JRJürgen Ripperger
Jürgen Ripperger
SLSonja Langmesser
Sonja Langmesser
Urs AlbrechtUrs Albrecht
Urs Albrecht
Circadian oscillations emerge from transcriptional and post-translational feedback loops. An important step in generating rhythmicity is the translocation of clock components into the nucleus, which is regulated in many cases by kinases. In mammals, the kinase promoting the nuclear import of the key clock component Period 2 (PER2) is unknown. Here, we show that the cyclin-dependent kinase 5 (CDK5) regulates the mammalian circadian clock involving phosphorylation of PER2. Knock-down of Cdk5 in the suprachiasmatic nuclei (SCN), the main coordinator site of the mammalian circadian system, shortened the free-running period in mice. CDK5 phosphorylated PER2 at serine residue 394 (S394) in a diurnal fashion. This phosphorylation facilitated interaction with Cryptochrome 1 (CRY1) and nuclear entry of the PER2-CRY1 complex. Taken together, we found that CDK5 drives nuclear entry of PER2, which is critical for establishing an adequate circadian period of the molecular circadian cycle. Of note is that CDK5 may not exclusively phosphorylate PER2, but in addition may regulate other proteins that are involved in the clock mechanism. Taken together, it appears that CDK5 is critically involved in the regulation of the circadian clock and may represent a link to various diseases affected by a derailed circadian clock.

27 April 2011 in FEBS Letters
Verified
Journal Article
Closed access
JRJürgen Ripperger
Jürgen Ripperger
MMMartha Merrow
Martha Merrow

8 August 2012
Verified
Book Chapter
Closed access
JRJürgen Ripperger
Jürgen Ripperger
Urs AlbrechtUrs Albrecht
Urs Albrecht